Is it amyotrophic lateral sclerosis or something else?
Gallagher, J.P.
Journal of the South Carolina Medical Association 82(1): 19-22
1986
ISSN/ISBN: 0038-3139 PMID: 3456470 Document Number: 279962
Document emailed within 1 workday
Related Documents
Alonso, K.; Medenica, R. 1995: Immunomodulation in the treatment of multiple sclerosis and amyotrophic lateral sclerosis: a model for autoimmune disorders Journal of the National Medical Association 87(8): 561-568Zavalishin, I.A.; Zakharova, M.N. 1999: Amyotrophic lateral sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 99(4): 60-64
Lupo, V.R.; Rusterholz, J.H.; Reichert, J.A.; Hanson, A.S. 1993: Amyotrophic lateral sclerosis in pregnancy Obstetrics and Gynecology 82(4 Pt 2(Suppl): 682-685
Antel, J.P.; Noronha, A.B.; Oger, J.J.; Arnason, B.G. 1982: Immunology of amyotrophic lateral sclerosis Advances in Neurology 36: 395-402
Vemireddi, N.K.; Crevoiserat, C.A. 1978: Amyotrophic lateral sclerosis in cancer Journal of the Mississippi State Medical Association 19(11): 201-204
Kuźma-Kozakiewicz, M.; Kwieciński, H. 2009: The genetics of amyotrophic lateral sclerosis Neurologia i Neurochirurgia Polska 43(6): 538-549
Kurtzke, J.F. 1982: Epidemiology of amyotrophic lateral sclerosis Advances in Neurology 36: 281-302
1995: Riluzole for amyotrophic lateral sclerosis Medical Letter on Drugs and Therapeutics 37(963): 113-114
Bouche, P.; Castaigne, P.; Meininger, V. 1989: Management of amyotrophic lateral sclerosis Revue Neurologique (Paris) 145(1): 49-54
Bali, T.; Miller, T.M. 2013: Management of amyotrophic lateral sclerosis Missouri medicine 110(5): 417-421
Barkhatova, V.P.; Zavalishin, I.A.; Kostiuk, A.V.; Demina, E.G.; Moskvitina, T.A. 1996: Neurotransmitter changes in amyotrophic lateral sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 96(4): 78-85
Krutsay, M.; Jakubovits, E. 1993: Rapid course amyotrophic lateral sclerosis Orvosi Hetilap 134(40): 2209-2211
Hirano, A. 1991: Cytopathology of amyotrophic lateral sclerosis Advances in Neurology 56: 91-101
Holmøy, T.; Worren, T. 2006: Communication aids in amyotrophic lateral sclerosis Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 126(19): 2523-2525
Ramelli, E. 1970: Prognostic factors in amyotrophic lateral sclerosis Acta Neurologica 25(4): 441-449
Ignatius, J. 1993: Free radicals as a cause of amyotrophic lateral sclerosis? Duodecim; Laaketieteellinen Aikakauskirja 109(12): 1041-1043
Wachi, M.; Uehara, K.; Fujinaka, W.; Takatori, M.; Tada, K. 2011: Use of sugammadex in a patient with amyotrophic lateral sclerosis Masui. Japanese Journal of Anesthesiology 60(12): 1408-1410
Chritin, M.; Besson, G.; Mallaret, M.; Savasta, M. 2001: Amyotrophic lateral sclerosis and animal models Revue Neurologique (Paris) 157(11 Part 1): 1351-1361
Nakano, I. 2006: Amyotrophic lateral sclerosis with dementia (ALSD) Rinsho Shinkeigaku 46(11): 822-824
Rothstein, J.D. 1995: Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis Clinical Neuroscience 3(6): 348-359